Key result
The ACE promoter SNP rs7213516 was associated with adverse cardiovascular outcomes in African Americans.
Why the study?
Do ACE promoter polymorphisms (rs4290 and rs7213516) increase the risk of adverse cardiovascular outcomes in hypertensive patients with coronary disease?
Observational (n=1,032)
Yes
Do ACE promoter polymorphisms (rs4290 and rs7213516) increase the risk of adverse cardiovascular outcomes in hypertensive patients with coronary disease?
Answers are grounded in this paper and cite their sources.
ACE promoter polymorphisms, particularly rs7213516, are strongly associated with an increased risk of nonfatal myocardial infarction in African American hypertensive patients with coronary disease.
Genetic variants of ACE are suspected risk factors in cardiovascular disease, but the alleles responsible for the variations remain unidentified. To search for regulatory polymorphisms, allelic angiotensin I-converting enzyme (ACE) mRNA expression was measured in 65 heart tissues, followed by genotype scanning of the ACE locus. Marked allelic expression imbalance (AEI) detected in five African-American subjects was associated with single-nucleotide polymorphisms (SNPs) (rs7213516, rs7214530, and rs4290) residing in conserved regions 2-3 kb upstream of ACE. Moreover, each of the SNPs affected transcription in reporter gene assays. SNPs rs4290 and rs7213516 were tested for associations with adverse cardiovascular outcomes in hypertensive patients with coronary disease (International Verapamil SR Trandolapril Study Genetic Substudy (INVEST-GENES), n = 1,032). Both SNPs were associated with adverse cardiovascular outcomes, largely attributable to nonfatal myocardial infarction in African Americans, showing an odds ratio of 6.16 (2.43-15.60) (P < 0.0001) for rs7213516. The high allele frequency in African Americans (16%) compared to Hispanics (4%) and Caucasians (<1%) suggests that these alleles contribute to variation between populations in cardiovascular risk and treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2008) conducted an observational in Hypertension with coronary disease (n=1,032). ACE promoter SNPs (rs7213516, rs7214530, and rs4290) vs. Absence of risk alleles was evaluated on Adverse cardiovascular outcomes (OR 6.16, 95% CI 2.43-15.60, p=< 0.0001). The ACE promoter SNP rs7213516 was associated with adverse cardiovascular outcomes in African Americans.
Synapse has enriched 10 related papers. Consider them for comparative context: